Patents 108show all

  • 13
    A61K - Preparations for medical, dental, or toilet purposes
  • 13
    C07K - Peptides
  • 12
    C07D - Heterocyclic compounds
  • 11
    C12N - Microorganisms or enzymes
  • 11
    C12Y - Enzymes
  • 11
    G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology
  • 10
    C07C - Acyclic or carbocyclic compounds
  • 6
    B82Y - Specific uses or applications of nanostructures
  • 6
    C08B - Polysaccharides
  • 6
    C08L - Compositions of macromolecular compounds

Clinical Trials 11show all

4Phase 2/Phase 34Phase 32N/A1Phase 2

SEC Filings show all


33
8-K

8
10-Q

3
D

2
10-K

1
S-1

Contact Information

San Diego, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-02-17$50,000,011$10,806,610Equity
2009-11-23$20,024,000$11,999,999Equity, Option to Acquire
2009-05-22$7,673,456$7,673,456Equity

Key Executives

  • William Rastetter
    Executive Officer, Director
  • Raymond Stevens
    Director
  • Robert Nelson
    Director
  • Michael Sheffery
    Director
  • James Schmidt
    Executive Officer
  • Robert Nelsen
    Director
  • Ed Torres
    Director
  • Doug Cole
    Director
  • Paul Grayson
    Director
  • Kristina Burow
    Director
  • Amir Nashat
    Director
  • Faheem Hasnain
    Executive Officer, Director
  • Sheila Gujrathi
    Executive Officer
  • Marcus Boehm
    Executive Officer
  • Robert Peach
    Executive Officer
  • Chrysa Mineo
    Executive Officer